Centene Corp (CNC) stock
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/307% above fair value
$72.55−2.22 (-2.97%)
Close on Nov 17, 2026Market cap $35.92BP/E 24.8Yield –
Centene operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Centene's operating cash flow for the twelve months ending Sep 30, 2026 was $4.72B, up 16.2% year over year. For fiscal 2025 it was $5.09B, up 3203.9% from the year before. Over ten years it grew 22.7% a year on average. The highest annual figure on record is $8.05B in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.09B | +3203.9% |
| FY2024 | Dec 31, 2024 | $154.00M | -98.1% |
| FY2023 | Dec 31, 2023 | $8.05B | +28.6% |
| FY2022 | Dec 31, 2022 | $6.26B | +48.9% |
| FY2021 | Dec 31, 2021 | $4.21B | -23.6% |
| FY2020 | Dec 31, 2020 | $5.50B | +271.1% |
| FY2019 | Dec 31, 2019 | $1.48B | +20.2% |
| FY2018 | Dec 31, 2018 | $1.23B | -17.1% |
| FY2017 | Dec 31, 2017 | $1.49B | -19.6% |
| FY2016 | Dec 31, 2016 | $1.85B | +181.3% |
| FY2015 | Dec 31, 2015 | $658.00M | -46.2% |
| FY2014 | Dec 31, 2014 | $1.22B | +220.2% |
| FY2013 | Dec 31, 2013 | $382.00M | +36.9% |
| FY2012 | Dec 31, 2012 | $279.00M | +6.6% |
| FY2011 | Dec 31, 2011 | $261.70M | +54.9% |
| FY2010 | Dec 31, 2010 | $168.93M | -31.9% |
| FY2009 | Dec 31, 2009 | $248.20M | +11.8% |
| FY2008 | Dec 31, 2008 | $221.98M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.67B | -370.6% |
| Q2 FY2026 | Jun 30, 2026 | $3.59B | +101.1% |
| Q1 FY2026 | Mar 31, 2026 | $4.37B | +189.1% |
| Q4 FY2025 | Dec 31, 2025 | $437.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $1.36B | – |
| Q2 FY2025 | Jun 30, 2025 | $1.79B | -17.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.51B | – |
| Q4 FY2024 | Dec 31, 2024 | -$587.00M | -370.5% |
| Q3 FY2024 | Sep 30, 2024 | -$978.00M | -195.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.18B | -14.6% |
| Q1 FY2024 | Mar 31, 2024 | -$456.00M | -110.7% |
| Q4 FY2023 | Dec 31, 2023 | $217.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.02B | -69.4% |
| Q2 FY2023 | Jun 30, 2023 | $2.55B | -24.1% |
| Q1 FY2023 | Mar 31, 2023 | $4.27B | +270.9% |
| Q4 FY2022 | Dec 31, 2022 | -$1.58B | -333.5% |
| Q3 FY2022 | Sep 30, 2022 | $3.33B | +84.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.35B | +99.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.15B | +2576.7% |
| Q4 FY2021 | Dec 31, 2021 | $675.00M | -77.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.80B | – |
| Q2 FY2021 | Jun 30, 2021 | $1.69B | -54.6% |
| Q1 FY2021 | Mar 31, 2021 | $43.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.98B | – |
| Q3 FY2020 | Sep 30, 2020 | -$952.00M | – |
| Q2 FY2020 | Jun 30, 2020 | $3.71B | +305.0% |
| Q1 FY2020 | Mar 31, 2020 | -$240.00M | -118.2% |
| Q4 FY2019 | Dec 31, 2019 | -$651.00M | – |
| Q3 FY2019 | Sep 30, 2019 | -$99.00M | -118.1% |
| Q2 FY2019 | Jun 30, 2019 | $917.00M | – |
| Q1 FY2019 | Mar 31, 2019 | $1.32B | -28.7% |
| Q4 FY2018 | Dec 31, 2018 | -$634.00M | -240.9% |
| Q3 FY2018 | Sep 30, 2018 | $548.00M | +464.9% |
| Q2 FY2018 | Jun 30, 2018 | -$526.00M | – |
| Q1 FY2018 | Mar 31, 2018 | $1.85B | +47.9% |
| Q4 FY2017 | Dec 31, 2017 | $450.00M | -71.7% |
| Q3 FY2017 | Sep 30, 2017 | $97.00M | – |
| Q2 FY2017 | Jun 30, 2017 | -$306.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.25B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.59B | – |
See a number that looks wrong?